| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2022 |
3
| Watson W. Mark (Director) has filed a Form 3 on Tekla World Healthcare Fund |
| 06/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2022 |
4
| Watson W. Mark (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 90,663 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 54,740 options to buy
@ $2.93, valued at
$160.4k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 01/31/2022 |
4
| Watson W. Mark (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 85,760 options to buy
@ $3.66, valued at
$313.9k
Granted 15,369 restricted stock units
@ $0
Exercised 7,684 restricted stock units
@ $0 |
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 1,306,452 options
@ $0.031, valued at
$40.5k
|
|
| 11/23/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 181 shares
@ $37.9, valued at
$6.9k
|
|
| 11/13/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 1,000 shares
@ $37.2, valued at
$37.2k
|
|
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 181 shares
@ $25.95, valued at
$4.7k
|
|
| 05/13/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 1,000 shares
@ $25, valued at
$25k
|
|
| 03/30/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Sold 3,000 shares
@ $26.1, valued at
$78.3k
|
|
| 03/24/2020 |
4
| Watson W. Mark (Director) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 1,500,000 options
@ $0.05, valued at
$75k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/22/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 181 shares
@ $34.92, valued at
$6.3k
|
|
| 11/21/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 984 shares
@ $35.27, valued at
$34.7k
|
|
| 08/22/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 181 shares
@ $29.19, valued at
$5.3k
|
|
| 08/21/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on SYKES ENTERPRISES INC|
Txns:
| Granted 984 shares
@ $28.89, valued at
$28.4k
|
|
| 08/15/2019 |
4
| Watson W. Mark (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 24,739 restricted stock units
@ $0 |
|
|